Manufacturing

Cheryl Barton is director of PharmaVision, 

Articles

TreeFrog Therapeutics is leaping ahead in cell therapies through 
resources such as new technologies and investor partnerships.


Frontrunners in the Latest Stem Cell Technology

The combined solutions are currently available on the market.

TrakCel and Lonza Reach Integration Milestone to Combine Cell and Gene Therapy Manufacturing, Orchestration Solutions 

The new guidance provides detailed recommendations to drug developers with a target of helping to ensure that drug developers provide adequate information to assess potency at each stage of a product’s life cycle.

FDA Issues Guidance on Potency for mAbs and Therapeutic Proteins

Chris Spivey is the editorial director of 

Decreasing vein to vein time saves lives.

High-titer Vector Producing Cells

Bojiao Yin is director of Vector Process Development at ElevateBio.

Mercedes Segura Gally is vice-president of Vector Process Development at ElevateBio. 

Jimmy Xin is scientist at Vector Process Development, ElevateBio. 

 is scientist at Vector Process Development, ElevateBio.

There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.

Tactics and Strategies for Designing an Ideal Lentiviral Vector Platform

Feliza Mirasol is the science editor for 

A slew of late-stage clinical trials is expected to push new regenerative medicines onto the market in the next few years.

Robust Development Fuels Drive to Finish Line

Improvement in viral vector yield has become integral to new cell and gene therapy product development.

Optimizing Vectors to Standardize Success

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

In vivo CAR-T gene therapies could overcome the challenges faced by autologous and allogeneic treatments.

Technology for In Vivo CAR T-cell Therapy Advances

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

Manufacturing, Cell Therapies